Search All Resources
Innovative Strategies in Harm Reduction: Text-Based Care | March 1, 2022
Type: Past Presentation
Audience: Clinical Community
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #harm #hr #kit #naloxone #narcan #reduction #text #text-based
In this presentation, Dr. Samantha Gustafson, PharmD, describes the impact of the COVID-19 pandemic on harm reduction strategies, and identifies promising practices in text-based, contactless care.
Date added: 02/28/22
Moral Injury, Resilience, and Post-Traumatic Growth Amidst the COVID Response | March 1, 2022
Type: Past Presentation
Program: Grand Rounds
Keywords: #covid #moral injury #resilience #stress #trauma-informed care
In this presentation, Nomi Levy-Carrick, MD, MPhil, describes the difference between burnout and moral injury, provides examples of long-term consequences of toxic stress, and shares how Trauma-Informed Care and Psychological First Aid can support resilience among clinicians serving American Indian ...
Date added: 02/25/22
Behavioral Health ECHO | February 24, 2022
In this session, Behavioral Health ECHO faculty members and participants join in a discussion of the previous training, Cultural Based Strategies, held on January 27, 2022.
Date added: 02/24/22
Dementia and Safety | February 24, 2022
In this presentation, Debra Miller TDCS BSW/CSW discusses risks and safety concerns for individuals with dementia and offers practical solutions to plan for and increase safety.
Date added: 02/24/22
Syphilis in the ED: Why it Matters and What to Know | March 3, 2022
Type: Past Presentation
Audience: Clinical
Keywords: #covid-19 #emergency #std presentation #syphilis
We welcome you to join Indian Country ECHO for a special session focused on responding to the rise of syphilis rates in Indigenous communities. This session will cover syphilis’ reemergence and changing epidemiology, why Emergency Departments (EDs) are crucial players ...
Date added: 02/22/22
Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cure #hcc #hepatocellular carcinoma #svr
In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after achieving cure from hepatitis C virus.
Date added: 02/22/22
Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Highly Effective Biomedical Option | February 23, 2022
Type: Past Presentation
Audience: Clinical
Program: Grand Rounds
Keywords: #hiv #pre-exposure prophylaxis #prep
In this series of presentations focused on Pre-Exposure Prophylaxis (PrEP) for HIV Prevention, Dawn K. Smith, MD, MS, MPH, and Demetre Daskalakis, MD, MPH cover the evidence on effectiveness, monitoring, and best practices, including remote provision of PrEP care services. Then, CAPT ...
Date added: 02/21/22
Playlist: Midwest Tribal ECHO Past Presentations
Type: Past Presentation
Audience: Clinical
Program: Substance Use Disorder
Keywords: #Midwest tribal echo
This link is for a Youtube playlist of all Midwest Tribal ECHO past presentations.
Date added: 02/17/22
OB in the ED: Hemorrhage | February 17, 2022
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid-19 #emergency #hemorrhage #ob #obstetrics #pregnancy
In this presentation. Dr. Kelly Bogaert, MD, introduces the different types of hemorrhage possible in obstetric patients presenting to the Emergency Department, discusses the management of such situations, and provides an update on COVID-19 in pregnancy.
Date added: 02/16/22
Review of Efficacy and Safety of Novavax COVID Vaccine | Past pandemic/s and their outcome/s | February 16, 2022
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid-19 vaccines #novavax #plague
In this presentation, Dr. Thomas Weiser, MD, MPH, Medical Epidemiologist for the Portland Area Indian Health Service, Northwest Portland Area Indian Health Board and ECHO faculty member, reviews the safety and efficacy of the NVX-CoV2373 vaccine (Novavax COVID Vaccine) in ...
Date added: 02/16/22